Ticker Scorecard - NAMS Basics Company: NewAmsterdam Pharma Company IPO Date: February 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.72% Avg Daily Range (30 D): $0.42 | 1.93% Avg Daily Range (90 D): $0.50 | 2.34% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 89 Institutional Trades Total Inst.Trades: 349 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.35M Avg Closing Trade (30 D): $.99M Avg Closing Trade (90 D): $1.34M Avg Closing Volume: 59.86K     News Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A Dec 13, 2024 @ 10:16 PM NewAmsterdam Pharma Announces Closing of Upsized $... Source: N/A Dec 12, 2024 @ 2:37 AM NewAmsterdam Pharma Announces Pricing of Upsized $... Source: N/A Dec 10, 2024 @ 9:34 PM NewAmsterdam Pharma Announces Commencement of $300... Source: N/A Dec 10, 2024 @ 12:00 PM NewAmsterdam Pharma Announces Positive Topline Dat... Source: Newamsterdam Pharma Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.21 $-.18 Diluted EPS $-2.21 $-.18 Revenue $ 33.59M $ 29.11M $ Gross Profit $ $ $ Net Income / Loss $ -198.92M $ -16.65M $ Operating Income / Loss $ -184.13M $ -25M $ Cost of Revenue $ $ $ Net Cash Flow $ 48.07M $ $ PE Ratio